Germany
Japan
United Kingdom
China
Fluorescent Protein Antibodies
Download
CD3E mouse monoclonal antibody, clone MEM-92, Purified
| Applications | FC, FN, IP |
| Reactivities | Human |
CD61 (ITGB3) mouse monoclonal antibody, clone VIPL2, Aff - Purified
| Applications | FC, IHC, WB |
| Reactivities | Human, Primate |
USD 399.00
In Stock
CD41-CD61 Complex mouse monoclonal antibody, clone P2, Azide Free
| Applications | ELISA, FC, FN, IHC, IP |
| Reactivities | Human |
CD16 (FCGR3A) mouse monoclonal antibody, clone DJ130c, Purified
| Applications | FC, IHC |
| Reactivities | Human |
CD11b rat monoclonal antibody, clone M1/70.15, Purified
| Applications | FC, IF, IHC, IP, WB |
| Reactivities | Human, Mouse, Rabbit |
CD44 mouse monoclonal antibody, clone CVS18, Purified
| Applications | FC, IHC |
| Reactivities | Equine |
CD44 mouse monoclonal antibody, clone CVS18, PE, Purified
| Applications | FC |
| Reactivities | Equine |
| Conjugation | PE |
CD34 mouse monoclonal antibody, clone ICO-115, PE
| Applications | FC, IF |
| Reactivities | Human, Rat |
| Conjugation | PE |
CD3E mouse monoclonal antibody, clone PPT3, Biotin
| Applications | FC |
| Reactivities | Porcine |
| Conjugation | Biotin |
CD3E mouse monoclonal antibody, clone CA17.2A12, FITC
| Applications | FC |
| Reactivities | Canine |
| Conjugation | FITC |
CD45 (PTPRC) (CD45RB) mouse monoclonal antibody, clone MEM-55, Purified
| Applications | FC, IHC, IP |
| Reactivities | Human, Primate |
CD163 mouse monoclonal antibody, clone 5C6-FAT, Biotin
| Applications | FC, IHC, WB |
| Reactivities | Human |
| Conjugation | Biotin |
CD45 / LCA (CD45RB) rat monoclonal antibody, clone 16A, PE
| Applications | FC |
| Reactivities | Mouse |
| Conjugation | PE |
CD45 / LCA (CD45RB) rat monoclonal antibody, clone 16A, PE
| Applications | FC |
| Reactivities | Mouse |
| Conjugation | PE |
Cd68 rat monoclonal antibody, clone FA-11, FITC
| Applications | FC |
| Reactivities | Mouse |
| Conjugation | FITC |
CD45 (PTPRC) (CD45RC) mouse monoclonal antibody, clone MT2, Aff - Purified
| Applications | FC, IF, IHC |
| Reactivities | Human |
Cd44 rat monoclonal antibody, clone IM7.8.1, Purified
| Applications | ELISA, FC, IHC, IP, WB |
| Reactivities | Mouse |
CD11b (ITGAM) mouse monoclonal antibody, clone ICRF44, Purified
| Applications | FC, FN, IHC, IP |
| Reactivities | Human, Monkey |
CD11b (ITGAM) mouse monoclonal antibody, clone ICRF44, Purified
| Applications | FC, FN, IHC, IP |
| Reactivities | Human, Monkey |
CD56 (NCAM1) mouse monoclonal antibody, clone ERIC-1, Purified
| Applications | ELISA, IHC, WB |
| Reactivities | Human, Porcine |
Cd34 rat monoclonal antibody, clone MEC14.7, PE
| Applications | FC |
| Reactivities | Mouse |
| Conjugation | PE |
Cd3d mouse monoclonal antibody, clone 1F4, Purified
| Applications | FC, FN, IHC, IP |
| Reactivities | Rat |
CD61 (ITGB3) mouse monoclonal antibody, clone BV4, Purified
| Applications | ELISA, FN, IHC, IP, WB |
| Reactivities | Bovine, Human |
CD163 mouse monoclonal antibody, clone 5C6-FAT, FITC
| Applications | FC |
| Reactivities | Human |
| Conjugation | FITC |
CD11b rat monoclonal antibody, clone M1/70.15, Purified
| Applications | FC, IF, IHC, IP |
| Reactivities | Human, Mouse, Rabbit |
CD68 mouse monoclonal antibody, clone 514H12, Supernatant
| Applications | IF, IHC |
| Reactivities | Human |
CD45 (PTPRC) (CD45RB) mouse monoclonal antibody, clone MEM-55, Purified
| Applications | FC, IHC, IP, WB |
| Reactivities | Human, Primate |
TMEM16A (ANO1) mouse monoclonal antibody, clone DOG1.1, Supernatant
| Applications | IHC |
| Reactivities | Human |
CD68 mouse monoclonal antibody, clone C68/684, Purified
| Applications | FC, IF, IHC, IP, WB |
| Reactivities | Human, Monkey |
CD45 / LCA rat monoclonal antibody, clone YW 62.3, Purified
| Applications | FC, IHC, IP |
| Reactivities | Mouse |
CD45 / LCA rat monoclonal antibody, clone YW 62.3, Purified
| Applications | FC, IHC, IP |
| Reactivities | Mouse |
CD55 / DAF mouse monoclonal antibody, clone 67, Purified
| Applications | FC, IHC |
| Reactivities | Human |
Active filters
Clonalities
- Monoclonal
Filter by
Target Symbol
- CD68 (126)
- PTPRC (108)
- CD44 (90)
- CD33 (84)
- CD19 (82)
- NCAM1 (72)
- KIT (71)
- CD163 (67)
- CD34 (63)
- FCGR2A (63)
- CD22 (58)
- CD38 (52)
- CD3E (52)
- MME (40)
- IL3RA (27)
- FCGR3A (26)
- CD7 (18)
- ITGB3 (16)
- ITGAM (15)
- ITGA2B (9)
- ITGA4 (7)
- ITGB2 (7)
- CD55 (6)
- CD247 (5)
- FLT3 (5)
- KLRD1 (5)
- LTBR (5)
- FCGR2B (4)
- ITGA3 (3)
- ITGA5 (3)
- ITGAX (3)
- CCR3 (2)
- CD16 (2)
- CD16 (FCGR3A) (2)
- GYPA (2)
- ITGA6 (2)
- ITGB7 (2)
- CALD1 (1)
- CD10 (1)
- CD3D (1)
- CD3G (1)
- FCGR2 (1)
Reactivities
Applications
Antibody Hosts
Isotypes
Conjugates
Knockout (KO) Validation
Modifications
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG1 format, for improved compatibility with existing reagents, assays and techniques. (12)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2a format, for improved compatibility with existing reagents, assays and techniques. (12)
- This chimeric rabbit antibody was made using the variable domain sequences of the original murine IgG1 format, for improved compatibility with existing reagents, assays and techniques. (4)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. (3)
- This chimeric mouse antibody was made using the variable domain sequences of the original Hamster IgG1 format, for improved compatibility with existing reagents, assays and techniques. (2)
- This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques. (2)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Hamster IgG1 format, for improved compatibility with existing reagents, assays and techniques. (2)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG2a format, for improved compatibility with existing reagents, assays and techniques. (2)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG2b format, for improved compatibility with existing reagents, assays and techniques. (2)
- This chimeric rabbit antibody was made using the variable domain sequences of the original murine IgG2b format, for improved compatibility with existing reagents, assays and techniques. (2)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques. (1)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques. (1)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric rabbit antibody was made using the variable domain sequences of the original human IgG4 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric mouse antibody was made using the variable domain sequences of the original Human format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Hamster IgG2 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Human format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2b format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original rat IgG2b format, for improved compatibility with existing reagents, assays and techniques. (1)
- This constant region of this antibody has been modified to bind to Protein A, allowing highly-specific purification of this antibody by Protein A-affinity column. (1)
- This is a chimeric mouse antibody, based on the original hamster IgG format, created for improved compatibility with existing reagents, assays and techniques. (1)
- This is a reformatted human IgG1 antibody based on the therapeutic Fab fragment. NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. (1)
- This reformatted mouse antibody was made using the variable domain sequences of the original Mouse IgG format, for improved compatibility with existing reagents, assays and techniques. (1)
Assay Types
Assay Platforms
Families
- Transmembrane (1035)
- Druggable Genome (927)
- ES Cell Differentiation/IPS (526)
- Adult stem cells (213)
- Embryonic stem cells (213)
- Cancer stem cells (169)
- Phosphatase (98)
- Secreted Protein (89)
- Stem cell relevant signaling - DSL/Notch pathway (84)
- Protein Kinase (75)
- Stem cell - Pluripotency (70)
- Protease (35)
- Induced pluripotent stem cells (26)
Pathways
- Hematopoietic cell lineage (582)
- Cell adhesion molecules (CAMs) (294)
- Primary immunodeficiency (201)
- Fc gamma R-mediated phagocytosis (184)
- T cell receptor signaling pathway (129)
- B cell receptor signaling pathway (126)
- Lysosome (125)
- ECM-receptor interaction (105)
- Cytokine-cytokine receptor interaction (100)
- Systemic lupus erythematosus (86)
- Pathways in cancer (81)
- Acute myeloid leukemia (75)
- Endocytosis (70)
- Melanogenesis (70)
- Prion diseases (69)
- Alzheimer's disease (35)
- Regulation of actin cytoskeleton (35)
- Renin-angiotensin system (35)
- Natural killer cell mediated cytotoxicity (33)
- Calcium signaling pathway (26)
- Metabolic pathways (26)
- Nicotinate and nicotinamide metabolism (26)
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) (21)
- Dilated cardiomyopathy (21)
- Focal adhesion (21)
- Hypertrophic cardiomyopathy (HCM) (21)
- Apoptosis (20)
- Jak-STAT signaling pathway (20)
- Leukocyte transendothelial migration (13)
- Small cell lung cancer (6)
- Antigen processing and presentation (5)
- Graft-versus-host disease (5)
- Viral myocarditis (4)
- Complement and coagulation cascades (2)
- Vascular smooth muscle contraction (1)